← Leaderboards
Barry D Quart
Napo Pharmaceuticals, Inc.
$589,041
Attributed
$589,041
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $477.6K · FY2006–07$500K$375K$250K$125K$0
'06
'07
Funding mix
By agency
NIH$589,041 · 1
By mechanism
U01$589,041 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Asia”
- Wafaa M. El-Sadr · Columbia University Health Sciences$167,022,351
- Myron S Cohen · Family Health International$146,816,419
- Constance Ann Benson · University Of California, San Diego$121,929,528
- Sten H Vermund · University Of Alabama At Birmingham$119,450,092
- Daniel R Kuritzkes · Brigham And Women'S Hospital$101,405,551
- Susan H Eshleman · Johns Hopkins University$92,035,670
Research focus
AsiaBangladeshBiodefenseCategoriesCholeraCholera ToxinClinical TrialsClinical Trials, OtherConditionCritical PathwaysCyclic GmpCystic Fibrosis Transmembrane Conductance RegulatorDiarrheaDisease OutbreaksDosage FormsEnteralEnterotoxigenic Escherichia ColiEvaluationFloodsFormulations, DrugFundingGastrointestinalGrantIntestines, Small